Comparison of pituitary-adrenal responsiveness between insulin tolerance test and growth hormone-releasing peptide-2 test: A pilot study

Peptides

Volumn 31, Issue 4, 2010, Pages 657-661

  Kano, Toshiko ^a   Sugihara, Hitoshi ^a   Sudo, Mariko ^a   Nagao, Mototsugu ^a   Harada, Taro ^a   Ishizaki, Akira ^a   Nakajima, Yasushi ^a   Tanimura, Kyouko ^a   Okajima, Fumitaka ^a   Tamura, Hideki ^a   Ishii, Shinya ^a   Shibasaki, Tamotsu ^a   Oikawa, Shinichi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

GHRP 2; HPA axis; Insulin tolerance test

Indexed keywords

CORTICOTROPIN; GLUCOSE; HUMAN INSULIN; HYDROCORTISONE; PRALMORELIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DIAGNOSTIC VALUE; ENDOCRINE FUNCTION TEST; FEMALE; FLUSHING; HEART PALPITATION; HORMONE RESPONSE; HUMAN; HUNGER; HYDROCORTISONE BLOOD LEVEL; HYPOGLYCEMIA; HYPOPITUITARISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN TOLERANCE TEST; INTERMETHOD COMPARISON; MALE; PILOT STUDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; SWEATING;

ADRENOCORTICOTROPIC HORMONE; ADULT; BIOLOGICAL ASSAY; CORTICOTROPIN-RELEASING HORMONE; FEMALE; HUMANS; HYDROCORTISONE; HYPOPITUITARISM; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INSULIN; MALE; MIDDLE AGED; OLIGOPEPTIDES; PILOT PROJECTS; PITUITARY-ADRENAL SYSTEM;

EID: 77649234516     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.12.023     Document Type: Article

References (26)

1. Arlt W., and Allolio B. Adrenal insufficiency. Lancet 361 (2003) 1881-1893
2. Arvat E., Maccagno B., Ramunni J., Di Vito L., Broglio F., Deghenghi R., et al. Hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans. Neuroendocrinology 66 (1997) 432-438
3. Arvat E., Maccagno B., Ramunni J., Di Vito L., Gianotti L., Broglio F., et al. Effect of dexamethasone and alprazolam, a benzodiazepine, on the stimulatory effect of hexarelin, a synthetic GHRP, on ACTH, cortisol and GH secretion in humans hexarelin, a synthetic growth-hormone releasing peptide, shows no interaction with corticotropin-releasing hormone and vasopressin on adrenocorticotropin and cortisol secretion in humans. Neuroendocrinology 67 (1998) 310-316
4. Borm K., Slawik M., Seiler L., Flohr F., Petrick M., Honegger J., et al. Is the plasma ACTH concentration a reliable parameter in the insulin tolerance test?. Eur J Endocrinol 149 (2003) 535-541
5. Bowers C.Y., Momany F.A., Reynolds G.A., and Hong A. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 114 (1984) 1537-1545
6. Chihara K., Shimatsu A., Hizuka N., Tanaka S., Seino Y., Kato Y., and For the KP-102 study group. A simple diagnostic test using GH-releasing peptide-2 in adult GH deficiency. Eur J Endocrinol 157 (2007) 19-27
7. Coiro V., Saccani-Jotti G., Minelli R., Melani A., Milli B., Manfredi G., et al. Adrenocorticotropin/cortisol and arginine-vasopressin secretory patterns in response to ghrelin in normal men. Neuroendocrinology 81 (2005) 103-106
8. Elias K.A., Ingle G.S., Burnier J.P., Hammonds R.G., McDowell R.S., Rawson T.E., et al. In vitro characterization of four novel classes of growth hormone-releasing peptide. Endocrinology 136 (1995) 5694-5699
9. Erturk E., Jaffe C.A., and Barkan A.L. Evaluation of the integrity of the hypothalamic-pituitary-adrenal axis by insulin hypoglycemia test. J Clin Endocrinol Metab 83 (1998) 2350-2354
10. Ghigo E., Arvat E., Broglio F., Giordano R., Gianotti L., Muccioli G., et al. Endocrine and non-endocrine activities of growth hormone secretagogues in humans. Horm Res 51 Suppl. 3 (1999) 9-15
11. Giordano R., Picu A., Bonelli L., Balbo M., Berardelli R., Marinazzo E., et al. Hypothalamus-pituitary-adrenal axis evaluation in patients with hypothalamo-pituitary disorders: comparison of different provocative tests. Clin Endocrinol (Oxf) 68 (2008) 935-941
12. Grinspoon S.K., and Biller B.M.K. Laboratory assessment of adrenal insufficiency. J Clin Endocrinol Metab 79 (1994) 923-931
13. Hirotani C., Oki Y., Ukai K., Okuno T., Kurasaki S., Ohyama T., et al. ACTH releasing activity of KP-102 (GHRP-2) in rats is mediated mainly by release of CRF. Naunyn Schmiedebergs Arch Pharmacol 371 (2005) 54-60
14. Howard H.D., Feighner S.D., Cully D.F., Arena J.P., Liberator P.A., Rosenblum C.I., et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273 (1996) 974-977
15. Jones S.L., Trainer P.J., Perry L., Wass J.A., Bessser G.M., and Grossman A. An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year. Clin Endocrinol (Oxf) 41 (1994) 123-128
16. Kageyama K., Nigawara T., Sakihara S., Takayasu S., Terui K., Moriyama T., et al. Diagnostic usefulness of the growth hormone-releasing peptide-2 test as a substitute for the insulin tolerance test in hypopituitarism. Endocr J 55 (2008) 777-783
17. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999) 656-660
18. Korbonits M., Kaltsas G., Perry L.A., Putignano P., Grossman A.B., Besser G.M., et al. The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin. J Clin Endocrinol Metab 84 (1999) 2489-2495
19. Maghnie M., Uga E., Temporini F., Di Iorgi N., Secco A., Tinelli C., et al. Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic-pituitary disorders: comparison between insulin-induced hypoglycemia, low-dose ACTH, standard ACTH and CRH stimulation tests. Eur J Endocrinol 152 (2005) 735-741
20. Melmed S., and Kronenberg H.M. Anterior pituitary. In: Kronenberg H.M., Melmed S., Polonsky K.S., and Larsen P.R. (Eds). Williams textbook of endocrinology (2008), Saunders Elsevier Inc., Philadelphia 155-285
21. Muccioli G., Tschöp M., Papotti M., Deghenghi R., Heiman M., and Ghigo E. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur J Pharmacol 440 (2002) 235-254
22. Salvatori R. Adrenal insufficiency. J Am Med Assoc 294 (2005) 2481-2488
23. Schmidt I.L., Lahner H., Mann K., and Petersenn S. Diagnosis of adrenal insufficiency: evaluation of the corticotropin-releasing hormone test and basal serum cortisol in comparison to the insulin tolerance test in patients with hypothalamic-pituitary-adrenal disease. J Clin Endocrinol Metab 88 (2003) 4193-4198
24. Thomas G.B., Fairhall K.M., and Robinson I.C. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats. Endocrinology 138 (1997) 1585-1591
25. Tuchelt H., Dekker K., Bahr V., and Oelkers W. Dose-response relationship between plasma ACTH and serum cortisol in the insulin-hypoglycemia test in 25 healthy subjects and 109 patients with pituitary disease. Clin Endoclinol 53 (2000) 301-307
26. Wren A.M., Small C.J., Fribbens C.V., Neary N.M., Ward H.L., Seal L.J., et al. The hypothalamic mechanisms of the hypophysiotropic action of ghrelin. Neuroendocrinology 76 (2002) 316-324